Earlier today a book excerpt was released in which it was revealed that Alex Rodriguez received therapeutic use exemptions from Major League Baseball for performance enhancing drugs, including testosterone, for at least the 2007 and 2008 seasons.
A few moments ago, Major League Baseball issued the following statement:
“All decisions regarding whether a player shall receive a therapeutic use exemption (TUE) under the Joint Drug Program are made by the Independent Program Administrator (IPA) in consultation with outside medical experts, with no input by either the Office of the Commissioner or the Players Association. The process is confidentially administered by the IPA, and MLB and the MLBPA are not even made aware of which players applied for TUEs.
“The TUE process under the Joint Drug Program is comparable to the process under the World Anti-Doping Code. The standard for receiving a TUE for a medication listed as a performance-enhancing substance is stringent, with only a few such TUEs being issued each year by the IPA. MLB and the MLBPA annually review the TUE process to make sure it meets the most up-to-date standards for the issuance of TUEs.
“As recommended by the Mitchell Report, since 2008 MLB and the MLBPA have publicly issued the IPA’s annual report, which documents how many TUEs were granted for each category of medication. We believe this high level of transparency helps to ensure the proper operation of the TUE process.”
One can’t take issue with any of the facts asserted in that statement. However, the “since 2008” thing about TUE allowances doesn’t address what A-Rod was doing in 2007, which is when it was reported he received a TUE for testosterone. Also, the reference to the Independent Program Administrator and his or her consultations with “outside medical experts” ignores the fact that, per the excerpt in the book, baseball did not yet have an expert medical panel to advise the IPA in 2007.
So, yes, the system for TUE may be excellent now. But it was not the same in 2007 and before, and I believe the claims in the book excerpt still raise some interesting questions about how baseball handled such matters in the past and what — and why — A-Rod was allowed to take legally before he turned to illegal means to obtain performance enhancing drugs.
Twins’ right-hander Nick Burdi is set to undergo Tommy John surgery on his right elbow, the team announced on Friday. Burdi made 14 appearances for Double-A Chattanooga before succumbing to a torn ulnar collateral ligament and is not expected to make his major league debut until mid-2018 at the earliest. A UCL tear doesn’t always require Tommy John surgery — less severe cases can be treated with platelet-rich plasma injections, for example — but Twins’ chief baseball officer Derek Falvey told the press that surgery was unavoidable as Burdi had sustained a “full thickness tear” in his elbow.
Entering the 2016 season, Burdi was widely considered a top ten prospect in the Twins’ system. His exceptional velocity and potent fastball-slider combo made him a fearsome relief option as he came off of his first season in Double-A Chattanooga in 2015. During the 2016 season, however, the 24-year-old experienced a significant setback after a bone bruise cut his season short in late July. Prior to Friday’s diagnosis, he appeared to be staging an impressive comeback with the Chattanooga Lookouts this spring, decorating his efforts with a sparkling 0.53 ERA, 2.1 BB/9 and 10.6 SO/9 over 17 innings.
It’s a tough break for the Twins, whose farm system was ranked 21st in the league by Baseball America. “Obviously he’s proven when he’s healthy he’s an absolute premium prospect, and the Twins are treating him that way,” Burdi’s agent, Matt Sosnick, told Mike Berardino of the Pioneer Press. “We just want to make sure everything we do ultimately leads to the goal of getting him back on the field as quickly as he can.”
Things have gone from bad to worse for Red Sox’ outfielder Brock Holt, who was shut down “for the foreseeable future” on Friday after meeting with head trauma specialist Michael Collins. The Red Sox placed Holt on the 10-day disabled list in April after he began experiencing vertigo, the latest in a series of head injuries he’s sustained since last spring.
According to the Boston Herald’s Jason Mastrodonato, the outfielder was initially advised to attempt playing through his symptoms, but it quickly became apparent that the strategy wasn’t going to work. Now, the plan is to shut him down from any game activity in the hopes that he’ll be able to recover from all lingering symptoms before returning to the roster. Club manager John Farrell told reporters that the 28-year-old is still cleared to take batting practice and work on his defense, but won’t continue his rehab starts in Triple-A Pawtucket for the time being.
Holt had been making regular appearances for the Pawtucket Red Sox and was batting .209/.292/.372 with two home runs through 14 games this spring. This season marks his fifth run within the Red Sox’ organization. He experienced a bit of a slump at the plate in 2016 and slashed .255/.322/.383 after breaking out during his first All-Star year in 2015.
Pete Abraham of the Boston Globe suggests that the team’s concern for Holt extends past his setbacks at the plate. It’s still a long road to a full recovery, and while Farrell told reporters he believes the outfielder is on track to make a return sometime in 2017, he’ll need to make sure that Holt is both physically and mentally prepared to do so.